This resource is no longer available
The pandemic has fast-tracked the adoption of decentralized trials, which means new approaches and technology are essential to help patients stay engaged.
Like every aspect of the drug development process, clinical trials are rife with potholes that can slowly chip away at progress and delay timelines. Thousands of dollars go into recruitment, engagement, and retention efforts, yet inevitably participants still drop out.
There are many reasons why this happens and when, which is why there is a need for ways to alleviate this ongoing burden. Some of these include:
- Making clinical trials more patient centric
- Incorporating better eConsent technology
- Increasing efficiencies in a remote environment
Read how patient engagement could improve with smarter decentralized trials technology.